Skip to content

Extra ablation beyond puLmonary vein Isolation Nurtures Elimination of atrial fibrillation, or not? (Ext-LINE) Study

Extra ablation beyond puLmonary vein Isolation Nurtures Elimination of atrial fibrillation, or not? (Ext-LINE) Study - Ext-LINE Study

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT1052230134
Enrollment
180
Registered
2023-11-22
Start date
2023-11-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial fibrillation Atrial fibrillation

Interventions

In ExTRa mapping-guided ablation group, atrial sites of high %NP (mean %NP >35% and low voltage <0.5 mV ) were ablated and ExTRa mapping-guided anatomical line ablation was added after pulmonary vein
atrial fibrillation, catheter ablation, ExTRa mapping

Sponsors

Nishiwaki Shushi
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: First time ablation procedure for persistent atrial fibrillation Patients who can be followed for at least 1-year after procedure Patients from who we get written informed consent

Exclusion criteria

Exclusion criteria: Patients with AF termination only by pulmonary vein isolation Patients who received ablation procedure or MAZE procedure for for atrial fibrillation before enrollment

Design outcomes

Primary

MeasureTime frame
Atrial arrhythmia recurrence beyond 90 days after catheter ablation for atrial fibrillation

Secondary

MeasureTime frame
Cardiac function after procedure Atrial fibrillation-free survival, atrial tachycardia-fre e survival Atrial fibrillation termination rate Procedure detail (procedure time, ablation numbe r, ablation region) Adverse events Atrial arrhythmia recurrence beyond 90 days after repeat procedures

Contacts

Public ContactTetsuma Kawaji

Affiliation Kyoto University Graduate School of M edicine

kawaji@kuhp.kyoto-u.ac.jp+81-75-751-4254

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026